Injured Endothelial Cell: A Risk Factor for Pulmonary Fibrosis

被引:19
|
作者
Zhao, Weiming [1 ]
Wang, Lan [1 ]
Wang, Yaxuan [1 ]
Yuan, Hongmei [1 ]
Zhao, Mengxia [1 ]
Lian, Hui [1 ]
Ma, Shuaichen [1 ]
Xu, Kai [1 ]
Li, Zhongzheng [1 ]
Yu, Guoying [1 ]
机构
[1] Henan Normal Univ, Inst Biomed Sci, Henan Ctr Outstanding Overseas Scientists Organ Fi, Coll Life Sci,State Key Lab Cell Differentiat & Re, Xinxiang 453007, Peoples R China
关键词
pulmonary fibrosis; endothelial cells; endothelial-mesenchymal transition; myofibroblasts; TO-MESENCHYMAL TRANSITION; NF-KAPPA-B; GROWTH-FACTOR; TRANSCRIPTION FACTOR; CONTROLLED-TRIAL; STRESS; EXPRESSION; PERICYTES; TRANSFORMATION; MACROPHAGES;
D O I
10.3390/ijms24108749
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The pathological features of pulmonary fibrosis (PF) are the abnormal activation and proliferation of myofibroblasts and the extraordinary deposition of the extracellular matrix (ECM). However, the pathogenesis of PF is still indistinct. In recent years, many researchers have realized that endothelial cells had a crucial role in the development of PF. Studies have demonstrated that about 16% of the fibroblasts in the lung tissue of fibrotic mice were derived from endothelial cells. Endothelial cells transdifferentiated into mesenchymal cells via the endothelial-mesenchymal transition (E(nd)MT), leading to the excessive proliferation of endothelial-derived mesenchymal cells and the accumulation of fibroblasts and ECM. This suggested that endothelial cells, a significant component of the vascular barrier, played an essential role in PF. Herein, this review discusses E(nd)MT and its contribution to the activation of other cells in PF, which could provide new ideas for further understanding the source and activation mechanism of fibroblasts and the pathogenesis of PF.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Protective Effect of Granulocyte Colony Stimulating Factor on Human Retinal Endothelial Cell Injured by Oxidative Stress
    Kojima, H.
    Otani, A.
    Nakamura, H.
    Oishi, A.
    Usami, Y.
    Nakagawa, S.
    Yoshimura, N.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
  • [42] Injured skin as risk factor for chlorhexidine anaphylaxis
    Calogiuri, Gianfranco
    Garvey, Lene Heise
    Dileo, Elisabetta
    Nettis, Eustachio
    Vacca, Angelo
    Foti, Caterina
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2018, 6 (06): : 2177 - 2177
  • [43] Role of vascular endothelial growth factor in pulmonary endothelial cell injury by exercise challenge in asthmatic patients
    Kanazawa, H
    Tochino, Y
    Ichimaru, Y
    Kodama, T
    Kyoh, S
    Umeda, N
    JOURNAL OF ASTHMA, 2006, 43 (04) : 267 - 271
  • [44] Myeloid cell derived vascular endothelial growth factor promotes pulmonary metastasis by increasing endothelial permeability
    Rundqvist, H.
    Stockmann, C.
    Ponte, R.
    Doedens, A.
    Johnson, R. S.
    CLINICAL & EXPERIMENTAL METASTASIS, 2015, 32 (03) : 234 - 235
  • [45] VASCULAR ENDOTHELIAL GROWTH FACTOR: A ROLE IN FIBROSIS?
    Douglas, S. K.
    Millar, A. B.
    THORAX, 2008, 63 : A71 - A72
  • [46] Loss of myeloid cell-derived vascular endothelial growth factor accelerates fibrosis
    Stockmann, Christian
    Kerdiles, Yann
    Nomaksteinsky, Marc
    Weidemann, Alexander
    Takeda, Norihiko
    Doedens, Andrew
    Torres-Collado, Antonio X.
    Iruela-Arispe, Luisa
    Nizet, Victor
    Johnson, Randall S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (09) : 4329 - 4334
  • [47] Pulmonary Langerhans Cell Histiocytosis: Is Marijuana Smoking a Risk Factor?
    Martin, M.
    Pennington, K.
    Vassallo, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 201
  • [48] Circulating Vascular Endothelial Growth Factor in Idiopathic Pulmonary Fibrosis and Its Relation to Clinical Factors.
    Ando, M.
    Miyazaki, E.
    Nureki, S.
    Ueno, T.
    Kumamoto, T.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2009, 179
  • [49] Vascular endothelial growth factor and thrombospondin-1 in diffuse alveolar damage and advanced pulmonary fibrosis
    Matsubara, O
    Imazeki, N
    Okochi, Y
    Ozeki, Y
    Mark, EJ
    MODERN PATHOLOGY, 2001, 14 (01) : 223A - 223A
  • [50] Vascular endothelial growth factor and thrombospondin-1 in diffuse alveolar damage and advanced pulmonary fibrosis
    Matsubara, O
    Imazeki, N
    Okochi, Y
    Ozeki, Y
    Mark, EJ
    LABORATORY INVESTIGATION, 2001, 81 (01) : 223A - 223A